Processa Pharmaceuticals, Inc. PCSA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

67/100

4/6 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 Processa Pharmaceuticals, Inc. (PCSA), 包括 36 笔买入 和 7 笔卖出. 内部人买入总额为 $298.8K 内部人卖出总额为 $5.55K.

近期活跃的重要内部人包括 Skibsted Russell, Young David, Ng George K. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — PCSA

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2026-03-31	Skibsted Russell	Chief Financial Officer	知情买入	2,324	$2.54	$5.89K	2,324
2026-03-31	Young David	Pres. Research & Development	知情买入	1,810	$2.54	$4.59K	10,562
2026-03-31	Ng George K	Chief Executive Officer	知情买入	2,136	$2.54	$5.41K	3,649
2026-03-31	Baluch Khoso	Director	知情买入	2,269	$2.54	$5.75K	2,325
2026-03-31	Guy Wendy	Chief Administrative Officer	知情买入	1,854	$2.54	$4.7K	3,110
2026-03-31	Lin Patrick	Chief Business - Strategy Off	知情买入	1,603	$2.54	$4.06K	3,356
2026-03-31	Bigora Sian	Chief Development Officer	知情买入	2,107	$2.54	$5.34K	3,711
2026-03-31	Pannu Geraldine	Director	知情买入	2,072	$2.54	$5.25K	2,188
2026-03-31	Neal James R	Director	知情买入	789	$2.54	$2K	818
2026-01-01	Young David	Pres. Research & Development	期权行权（卖出）	49	-	-	-
2026-01-01	Guy Wendy	Chief Administrative Officer	期权行权（卖出）	193	-	-	-
2026-01-01	Lin Patrick	Chief Business - Strategy Off	期权行权（卖出）	193	-	-	-
2026-01-01	Bigora Sian	Chief Development Officer	期权行权（卖出）	249	-	-	-
2025-10-01	Skibsted Russell	Chief Financial Officer	限制性股票授予 (RSU)	108,000	-	-	108,000
2025-10-01	Yorke Justin W	Director	限制性股票授予 (RSU)	100,000	-	-	100,000
2025-10-01	Young David	Pres. Research & Development	限制性股票授予 (RSU)	111,000	-	-	111,000
2025-10-01	Neal James R	Director	限制性股票授予 (RSU)	100,000	-	-	100,000
2025-10-01	Ng George K	Chief Executive Officer	限制性股票授予 (RSU)	256,000	-	-	256,000
2025-10-01	Baluch Khoso	Director	限制性股票授予 (RSU)	100,000	-	-	100,000
2025-10-01	Guy Wendy	Chief Administrative Officer	限制性股票授予 (RSU)	50,000	-	-	50,000
2025-10-01	Lin Patrick	Chief Business - Strategy Off	限制性股票授予 (RSU)	68,000	-	-	68,000
2025-10-01	Bigora Sian	Chief Development Officer	限制性股票授予 (RSU)	96,000	-	-	96,000
2025-10-01	Pannu Geraldine	Director	限制性股票授予 (RSU)	100,000	-	-	100,000
2025-07-24	Skibsted Russell	Officer	未知	-	-	-	-
2025-07-24	Yorke Justin W	Officer	未知	-	-	-	-
2025-07-24	Young David	Officer	未知	-	-	-	-
2025-07-24	Ng George K	Officer	未知	-	-	-	-
2025-07-24	Guy Wendy	Officer	未知	-	-	-	-
2025-07-24	Lin Patrick	Officer	未知	-	-	-	-
2025-07-24	Bigora Sian	Officer	未知	-	-	-	-
2025-07-24	Skibsted Russell	Chief Financial Officer	限制性股票授予 (RSU)	1,775,044	-	-	1,803,044
2025-07-24	Yorke Justin W	Director	限制性股票授予 (RSU)	175,299	-	-	206,505
2025-07-24	Young David	Pres. Research & Development	限制性股票授予 (RSU)	1,813,133	-	-	1,821,016
2025-07-24	Neal James R	Director	限制性股票授予 (RSU)	175,299	-	-	206,505
2025-07-24	Ng George K	Chief Executive Officer	限制性股票授予 (RSU)	1,822,471	-	-	1,922,471
2025-07-24	Baluch Khoso	Director	限制性股票授予 (RSU)	175,299	-	-	206,505
2025-07-24	Guy Wendy	Chief Administrative Officer	限制性股票授予 (RSU)	1,366,046	-	-	1,376,478
2025-07-24	Lin Patrick	Chief Business - Strategy Off	限制性股票授予 (RSU)	1,401,650	-	-	1,412,082
2025-07-24	Bigora Sian	Chief Development Officer	限制性股票授予 (RSU)	1,659,185	-	-	1,672,087
2025-07-24	Pannu Geraldine	Director	限制性股票授予 (RSU)	175,299	-	-	206,505
2025-04-01	Young David	Pres. Research & Development	RSU 预扣税	5,345	$0.41	$2.2K	217,332
2025-04-01	Guy Wendy	Chief Administrative Officer	期权行权	14,482	-	-	26,339
2025-04-01	Lin Patrick	Chief Business - Strategy Off	RSU 预扣税	4,814	$0.41	$1.98K	38,727
2025-04-01	Bigora Sian	Chief Development Officer	RSU 预扣税	3,311	$0.41	$1.36K	33,626
2025-01-29	Yorke Justin W	Director	限制性股票授予 (RSU)	6,200	$0.65	$4.03K	6,200
2025-01-29	Young David	Pres. Research & Development	限制性股票授予 (RSU)	62,250	$0.65	$40.46K	62,250
2025-01-29	Ng George K	Chief Executive Officer	限制性股票授予 (RSU)	43,600	$0.65	$28.34K	43,600
2025-01-29	Lin Patrick	Chief Business - Strategy Off	限制性股票授予 (RSU)	21,750	$0.65	$14.14K	21,750
2025-01-27	Young David	Pres. Research & Development	知情买入	124,500	$0.80	$99.29K	205,405
2025-01-27	Ng George K	Chief Executive Officer	知情买入	87,200	$0.80	$69.54K	87,200